Tampa, Florida-based TuHURA Biosciences has completed its acquisition of Kineta, Inc., adding a Phase 2-ready VISTA-inhibiting monoclonal antibody to its pipeline of cancer immunotherapy treatments designed to overcome resistance mechanisms that limit current therapies. Key Points The acquisition positions TuHURA […]
South Korean medical device manufacturer HIRONIC held its inaugural Asia Innovation Summit in Bangkok on June 5th, bringing together 100 medical professionals and distributors from South Korea, Thailand, Vietnam, Malaysia, Indonesia, Myanmar, and other countries. The event focused on clinical
HIRONIC Hosts First Asian Summit for Non-Invasive Aesthetic Technologies Read More »
The BC Centre for Excellence in HIV/AIDS (BC-CfE) hosted a national summit in early June to address a troubling reality: The latest available government statistics for 2023 show a 35% uptick in HIV cases in Canada compared to 2022. Key
Rising HIV Cases Signal Crisis in Canadian Prevention Efforts Read More »
